Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg
Sponsor: Beijing Children's Hospital
Summary
In order to further observe the long-term safety and effectiveness of real-world polyethylene glycol-recombinant human growth hormone(PEG-rhGH) treatment of GHD, idiopathic short stature, and SGA in children, explore and analyze the factors affecting the efficacy of PEG-rhGH and the height prediction model after treatment, etc., collect and analyze more scientifically and rationally, and understand the situation of real-world PEG-GH treatment. A database registration study was developed.
Official title: A Real-world Study of the Efficacy and Safety of PEGylated Recombinant Human Growth Hormone Injection in the Treatment of Short Stature in Chinese Children From the Global Registry for Novel Therapies For Rare Bone or Endocrine Conditions
Key Details
Gender
All
Age Range
Any - 18 Years
Study Type
OBSERVATIONAL
Enrollment
2600
Start Date
2023-08-01
Completion Date
2029-08-01
Last Updated
2025-09-04
Healthy Volunteers
No
Conditions
Interventions
Polyethylene glycol recombinant human growth hormone injection
0.1-0.3mg/kg.w
Locations (1)
Department of Endocrinology, Genetics, Metabolism
Beijing, Beijing Municipality, China